Company Facts

Life Technologies at a Glance

Annual Sales Revenue $3.7 billion (2011)
Number of Employees 10,400
Number of Products 50,000+
Number of Patents and Exclusive Licenses 4,000+
Scientific Journal Citations 600,000+
Product Portfolio Instruments, reagents, technical services
Product Portfolio Medical & translational research, Human Identification, Forensics, Stem cell therapies, Genetic analysis, Genetic engineering, Agriculture biotechnology, Food saftey, Animal health
Brands Life Technologies™, Ambion®, Applied Biosystems®, Gibco®, Invitrogen™, Ion Torrent™, Molecular Probes®, Novex®, Taqman® and Novex®
Customers Scientists, laboratory workers worldwide
Number of Facilities 60+
Number of Countries where Life Technologies products are sold 160
Year Founded 2008 with the merger of Invitrogen and Applied Biosystems
Headquarters Carlsbad, California

Life Technologies Leadership & History

Leadership Team
Meet Life Technologies Leadership Team and read their biographies.
Company History
Life Technologies traces its roots back to the launch of Gibco in 1962. Learn more about our history and how we’ve grown.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today’s most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, GIBCO®, Ambion, Molecular® Probes, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011.